advertisement
Oddone F 19
Showing records 1 to 19 | Display all abstracts from Oddone F100590 Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?
Belamkar A
Journal of clinical medicine 2022; 11:
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
Oddone F
Clinical Ophthalmology 2022; 16: 1707-1719
100530 Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
Oddone F; Kirwan J
Advances in Therapy 2022; 39: 3501-3521
100590 Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?
Harris A
Journal of clinical medicine 2022; 11:
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
Scorcia V
Clinical Ophthalmology 2022; 16: 1707-1719
100590 Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?
Oddone F
Journal of clinical medicine 2022; 11:
100530 Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
Lopez-Lopez F
Advances in Therapy 2022; 39: 3501-3521
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
Iester M
Clinical Ophthalmology 2022; 16: 1707-1719
100530 Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
Zimina M
Advances in Therapy 2022; 39: 3501-3521
100590 Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?
Verticchio Vercellin A
Journal of clinical medicine 2022; 11:
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
Sisto D
Clinical Ophthalmology 2022; 16: 1707-1719
100590 Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?
Fabczak-Kubicka A
Journal of clinical medicine 2022; 11:
100530 Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
Fassari C
Advances in Therapy 2022; 39: 3501-3521
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
De Cilla S
Clinical Ophthalmology 2022; 16: 1707-1719
100530 Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
Holló G
Advances in Therapy 2022; 39: 3501-3521
100590 Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?
Siesky B
Journal of clinical medicine 2022; 11:
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
Bettin P; Cagini C
Clinical Ophthalmology 2022; 16: 1707-1719
100530 Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
Advances in Therapy 2022; 39: 3501-3521
100814 Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
Figus M; Marchini G; Rossetti L; Rossi G; Salgarello T; Scuderi GL; Staurenghi G;
Clinical Ophthalmology 2022; 16: 1707-1719
